Erbitux approved for metastatic colon cancer treatment in Europe

23/12/2013

(Reuters) - Erbitux is now approved to treat patients with RAS wild-type metastatic colorectal cancer by the European Commission.

The European Medicines Agency's Committee for Medicinal Products for Human Use, or CHMP, had recommended the approval in late November.

Source: Reuters: http://www.reuters.com/article/2013/12/23/merck-erbitux-idUSWEB00G7B20131223